# Exit Interviews to Assess Impact of Infusion Frequency in Hemophilia A

> **NCT02971930** · — · COMPLETED · sponsor: **Bayer** · enrollment: 30 (actual)

## Conditions studied

- Hemophilia A

## Interventions

- **BIOLOGICAL:** BAY94-9027

## Key facts

- **NCT ID:** NCT02971930
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-20
- **Primary completion:** 2017-11-26
- **Final completion:** 2017-12-15
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02971930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02971930, "Exit Interviews to Assess Impact of Infusion Frequency in Hemophilia A". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02971930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*